Search results for "Highlights"
Exercise and CBT are cost-effective for diabetes patients with depression
A study used simulation modeling to project the long-term effects of a three-month exercise and cognitive behavioral therapy (CBT) intervention for patients with type 2 diabetes and major depressive disorder. It found clear cost-effectiveness with the interventions alone or combined.
https://diabetes.acponline.org/archives/2021/03/12/3.htm
12 Mar 2021
More guideline-recommended diabetes care provided to older U.S. adults, not other age groups
From 2005 to 2018, the proportion of diabetes patients receiving care as recommended by the American Diabetes Association increased from 29.3% to 44.2% among those ages 65 years or older but did not change significantly for those ages 40 to 64 years (25.2% to 25.8%) or 20 to 39 years (9.9% to 26.0%).
https://diabetes.acponline.org/archives/2021/05/14/2.htm
14 May 2021
Biomarker score predicts heart failure risk with diabetes and prediabetes
The score, which was based on cardiac troponin, N-terminal pro-B-type natriuretic peptide, C-reactive protein, and electrocardiography, could be used to target specific therapies to the highest-risk patients, study authors said.
https://diabetes.acponline.org/archives/2021/01/08/3.htm
8 Jan 2021
SGLT-2 inhibitors linked to more diabetic ketoacidosis vs. DPP-4 inhibitors or sulfonylureas
A retrospective study found that new users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors developed diabetic ketoacidosis at a rate of about 6 per 1,000 person-years, compared to 4.3 or 4.5 per 1,000 person-years with dipeptidyl peptidase-4 (DPP-4) inhibitors or sulfonylureas, respectively.
https://diabetes.acponline.org/archives/2022/03/11/1.htm
11 Mar 2022
Patients with type 2 diabetes and all risk factors controlled still have increased CVD risk
Risk factor control was more strongly associated with mortality risk among patients with cardiorenal disease than those without, according to a retrospective British study.
https://diabetes.acponline.org/archives/2020/12/11/3.htm
11 Dec 2020
Balanced crystalloids may be preferred for acute resolution of diabetic ketoacidosis
A small subgroup analysis of two randomized trials found that median time to resolution of diabetic ketoacidosis was 13 hours in patients who received balanced crystalloids versus nearly 17 hours in those who received saline.
https://diabetes.acponline.org/archives/2020/12/11/2.htm
11 Dec 2020
Tirzepatide may improve glycemic control when added to insulin glargine in type 2 diabetes
An industry-sponsored phase 3 trial found statistically significant improvements in HbA1c level among patients with type 2 diabetes who had inadequate glycemic control on insulin glargine and were randomly assigned to subcutaneous tirzepatide once weekly versus placebo.
https://diabetes.acponline.org/archives/2022/02/11/1.htm
11 Feb 2022
Neurologists update guideline on treatment of painful diabetic neuropathy
The updated guideline from the American Academy of Neurology supports offering tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, gabapentinoids, and/or sodium channel blockers to reduce pain from diabetic neuropathy.
https://diabetes.acponline.org/archives/2022/01/14/1.htm
14 Jan 2022
Surgical, drug treatments have similar outcomes in patients with vitreous hemorrhage from proliferative diabetic retinopathy
A randomized trial found equivalent improvements in visual acuity at two years with either therapy but identified some differences in outcomes that could help patients and clinicians choose a treatment method.
https://diabetes.acponline.org/archives/2021/01/08/2.htm
8 Jan 2021
Studies find link between metformin and reduced COVID-19 mortality, mixed results for DPP-4 inhibitors
Prior metformin use was associated with a threefold decrease in mortality from COVID-19 in one study of patients with type 2 diabetes, while three other studies found mixed results on whether dipeptidyl peptidase-4 (DPP-4) inhibitors affect COVID-19 outcomes.
https://diabetes.acponline.org/archives/2021/02/12/2.htm
12 Feb 2021